These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 30938267)

  • 1. LRG is a novel inflammatory marker clinically useful for the evaluation of disease activity in rheumatoid arthritis and inflammatory bowel disease.
    Naka T; Fujimoto M
    Immunol Med; 2018 Jun; 41(2):62-67. PubMed ID: 30938267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leucine-rich α2 -glycoprotein as a potential biomarker for joint inflammation during anti-interleukin-6 biologic therapy in rheumatoid arthritis.
    Fujimoto M; Serada S; Suzuki K; Nishikawa A; Ogata A; Nanki T; Hattori K; Kohsaka H; Miyasaka N; Takeuchi T; Naka T
    Arthritis Rheumatol; 2015 May; 67(8):2056-60. PubMed ID: 25917892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum leucine-rich alpha-2 glycoprotein is a disease activity biomarker in ulcerative colitis.
    Serada S; Fujimoto M; Terabe F; Iijima H; Shinzaki S; Matsuzaki S; Ohkawara T; Nezu R; Nakajima S; Kobayashi T; Plevy SE; Takehara T; Naka T
    Inflamm Bowel Dis; 2012 Nov; 18(11):2169-79. PubMed ID: 22374925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leucine-rich Alpha-2 Glycoprotein is a Serum Biomarker of Mucosal Healing in Ulcerative Colitis.
    Shinzaki S; Matsuoka K; Iijima H; Mizuno S; Serada S; Fujimoto M; Arai N; Koyama N; Morii E; Watanabe M; Hibi T; Kanai T; Takehara T; Naka T
    J Crohns Colitis; 2017 Jan; 11(1):84-91. PubMed ID: 27466171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leucine-Rich Alpha-2 Glycoprotein in Monitoring Disease Activity and Intestinal Stenosis in Inflammatory Bowel Disease.
    Yoshida T; Shimodaira Y; Fukuda S; Watanabe N; Koizumi S; Matsuhashi T; Onochi K; Iijima K
    Tohoku J Exp Med; 2022 Jul; 257(4):301-308. PubMed ID: 35598974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leucine-rich alpha 2 glycoprotein promotes Th17 differentiation and collagen-induced arthritis in mice through enhancement of TGF-β-Smad2 signaling in naïve helper T cells.
    Urushima H; Fujimoto M; Mishima T; Ohkawara T; Honda H; Lee H; Kawahata H; Serada S; Naka T
    Arthritis Res Ther; 2017 Jun; 19(1):137. PubMed ID: 28615031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leucine-rich α2-glycoprotein as the acute-phase reactant to detect systemic juvenile idiopathic arthritis disease activity during anti-interleukin-6 blockade therapy: A case series.
    Shimizu M; Nakagishi Y; Inoue N; Mizuta M; Yachie A
    Mod Rheumatol; 2017 Sep; 27(5):833-837. PubMed ID: 28094589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Skin-Liver Axis Modulates the Psoriasiform Phenotype and Involves Leucine-Rich α-2 Glycoprotein.
    Nakajima H; Nakajima K; Takaishi M; Ohko K; Serada S; Fujimoto M; Naka T; Sano S
    J Immunol; 2021 Apr; 206(7):1469-1477. PubMed ID: 33648938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum leucine-rich α2 glycoprotein as a potential biomarker for systemic inflammation in Parkinson's disease.
    Ohmichi T; Kasai T; Shinomoto M; Kitani-Morii F; Fujino Y; Menjo K; Mizuno T
    PLoS One; 2023; 18(2):e0282153. PubMed ID: 36812242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum leucine-rich α2-glycoprotein is a useful biomarker for monitoring disease activity in patients with adult-onset Still's disease.
    Ha YJ; Kang EJ; Lee SW; Park YB; Lee SK; Song JS; Choi ST
    Scand J Rheumatol; 2015; 44(5):399-403. PubMed ID: 26079682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leucine rich α-2 glycoprotein is a potential urinary biomarker for renal tubular injury.
    Lee H; Fujimoto M; Ohkawara T; Honda H; Serada S; Terada Y; Naka T
    Biochem Biophys Res Commun; 2018 Apr; 498(4):1045-1051. PubMed ID: 29550485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. iTRAQ-based proteomic identification of leucine-rich alpha-2 glycoprotein as a novel inflammatory biomarker in autoimmune diseases.
    Serada S; Fujimoto M; Ogata A; Terabe F; Hirano T; Iijima H; Shinzaki S; Nishikawa T; Ohkawara T; Iwahori K; Ohguro N; Kishimoto T; Naka T
    Ann Rheum Dis; 2010 Apr; 69(4):770-4. PubMed ID: 19854709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum Leucine-Rich α2 Glycoprotein Could Be a Useful Biomarker to Differentiate Patients with Normal Colonic Mucosa from Those with Inflammatory Bowel Disease or Other Forms of Colitis.
    Horiuchi I; Horiuchi K; Horiuchi A; Umemura T
    J Clin Med; 2024 May; 13(10):. PubMed ID: 38792498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significance of Serum Leucine-rich Alpha-2 Glycoprotein as a Diagnostic Marker in Pediatric Inflammatory Bowel Disease.
    Yoshimura S; Okata Y; Ooi M; Horinouchi T; Iwabuchi S; Kameoka Y; Watanabe A; Kondo A; Uemura K; Tomioka Y; Samejima Y; Nakai Y; Nozu K; Kodama Y; Bitoh Y
    Kobe J Med Sci; 2024 Jan; 69(4):E122-E128. PubMed ID: 38379274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum Leucine-Rich Alpha-2 Glycoprotein in Quiescent Crohn's Disease as a Potential Surrogate Marker for Small-Bowel Ulceration detected by Capsule Endoscopy.
    Omori T; Sasaki Y; Koroku M; Murasugi S; Yonezawa M; Nakamura S; Tokushige K
    J Clin Med; 2022 Apr; 11(9):. PubMed ID: 35566620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ELISA for human serum leucine-rich alpha-2-glycoprotein-1 employing cytochrome c as the capturing ligand.
    Weivoda S; Andersen JD; Skogen A; Schlievert PM; Fontana D; Schacker T; Tuite P; Dubinsky JM; Jemmerson R
    J Immunol Methods; 2008 Jul; 336(1):22-9. PubMed ID: 18436231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum Leucine-Rich α2 Glycoprotein: A Biomarker for Predicting the Presence of Ulcerative Colitis but Not Ulcerative Proctitis.
    Horiuchi I; Horiuchi A; Umemura T
    J Clin Med; 2022 Oct; 11(21):. PubMed ID: 36362594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum leucine-rich α2-glycoprotein as a possible marker for inflammatory status in endometriosis.
    Kobayashi M; Nakamura O; Kitahara Y; Inoue N; Tsukui Y; Hasegawa Y; Hiraishi H; Yabuki A; Muraoka A; Osuka S; Iwase A
    Reprod Med Biol; 2023; 22(1):e12536. PubMed ID: 37608861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leucine-rich alpha-2 glycoprotein as a potential biomarker for large vessel vasculitides.
    Umezawa N; Mizoguchi F; Maejima Y; Kimura N; Hasegawa H; Hosoya T; Fujimoto M; Kohsaka H; Naka T; Yasuda S
    Front Med (Lausanne); 2023; 10():1153883. PubMed ID: 37215715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biomarkers for Monitoring of Changes in Disease Activity in Ulcerative Colitis.
    Tatsumi Y; Kakimoto K; Hara A; Mizuta N; Numa K; Kinoshita N; Nakazawa K; Koshiba R; Hirata Y; Ota K; Miyazaki T; Nakamura S; Sakagami K; Arimitsu S; Ito H; Nishikawa H
    J Clin Med; 2023 Nov; 12(22):. PubMed ID: 38002777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.